Related by context. All words. (Click for frequent words.) 69 posaconazole 69 ponatinib 68 tipranavir 68 lumiliximab 68 axitinib 67 radezolid 67 BAY #-# 67 velafermin 67 ganetespib 67 elotuzumab 67 riociguat 67 anidulafungin 67 bosutinib 67 invasive candidiasis 67 fidaxomicin 67 zalutumumab 67 enzastaurin 66 oral ridaforolimus 66 Viramidine 66 daptomycin 66 dalbavancin 66 tanespimycin 66 canakinumab 66 forodesine 66 doripenem 66 teriflunomide 66 Velcade bortezomib 66 pomalidomide 66 oral prodrug 66 rhThrombin 66 motavizumab 66 tigecycline 66 lapatinib Tykerb 66 ocrelizumab 66 LAF# 66 TroVax ® 66 pertuzumab 65 Cethromycin 65 adalimumab Humira 65 delafloxacin 65 Phase Ib study 65 APTIVUS 65 HuMax EGFr 65 mRCC 65 vidofludimus 65 Aptivus ® 65 nitazoxanide 65 mapatumumab 65 OHR/AVR# 65 cetuximab Erbitux 65 Aflibercept 65 CIMZIA ™ 65 micafungin 65 ZOLINZA 65 iniparib 65 eltrombopag 65 dacetuzumab 65 MAGE A3 ASCI 65 Dacogen injection 65 CIMZIA TM 65 Phase #b/#a 65 solithromycin 65 candidemia 65 pazopanib 65 BRIM2 65 BRAF inhibitor 65 T Pred 65 IMA# 65 Fludara 65 voriconazole 65 severe hypercholesterolemia 65 mycophenolate mofetil 65 HuMax CD# 65 ximelagatran 65 invasive aspergillosis 65 ASA# 64 Ambrisentan 64 oral FTY# 64 Onbrez Breezhaler 64 OncoVEX GM CSF 64 esophageal candidiasis 64 ZD# [001] 64 cangrelor 64 Zolinza 64 vandetanib 64 neratinib 64 JAK inhibitor 64 refractory CLL 64 apremilast 64 gemifloxacin 64 Noxafil 64 aclidinium 64 HuMax CD4 64 zanolimumab 64 Aptivus 64 Tarceva TM 64 APTIVUS r 64 aflibercept 64 regorafenib 64 sunitinib malate 64 phase IIb clinical 64 DASISION 64 BAL# [002] 64 Targretin 64 Celsentri Selzentry 64 ELACYT 64 tremelimumab 64 sorafenib Nexavar 64 Sprycel dasatinib 64 Mycograb 64 PRT# 64 Arixtra 64 Phase Ib clinical 64 Altastaph 64 elacytarabine 64 nucleotide analogue 64 Boceprevir 64 isavuconazole 64 ceftaroline 64 brivaracetam 64 talactoferrin 64 Phenoptin 64 OZURDEX ® 64 midstage clinical 64 Zometa zoledronic acid 64 Proxinium TM 64 ToGA 64 liprotamase 64 torezolid phosphate 64 investigational monoclonal antibody 64 Fablyn 64 Golimumab 64 Telbivudine 64 nosocomial pneumonia 64 Revlimid lenalidomide 63 Sym# 63 Interferon beta 1b 63 TYSABRI natalizumab 63 Nexavar sorafenib 63 relapsed MCL 63 clevidipine 63 olaparib 63 Phase IIIb clinical 63 refractory gout 63 Ceflatonin 63 valopicitabine 63 oxymorphone ER 63 ACZ# 63 gastrointestinal stromal tumors GIST 63 figitumumab 63 orBec 63 Aplidin 63 crizotinib PF # 63 ceftobiprole 63 pradefovir 63 boosted protease inhibitor 63 tocilizumab 63 LymphoStat B 63 huC# DM4 63 INCB# [001] 63 ARCOXIA 63 pegylated interferon alfa 63 diabetic neuropathic pain 63 EndoTAG TM -1 63 decitabine 63 REYATAZ R 63 HyQ 63 Aurexis 63 atacicept 63 SinuNase 63 Cimzia TM 63 eprotirome 63 icatibant 63 phase Ib 63 docetaxel Taxotere 63 phase IIb trial 63 intravenous bisphosphonates 63 imipenem 63 entecavir 63 recurrent GBM 63 rindopepimut 63 Phase 2a trial 63 adecatumumab 63 ImmunoVEX HSV2 63 Telintra 63 PROSTVAC TM 63 Bicifadine 63 alvespimycin 63 oral methylnaltrexone 63 caspofungin 63 obatoclax 63 Aliskiren 63 amrubicin 63 cediranib 63 FTY# 63 SPIRIVA HandiHaler 63 Afatinib 63 ACTEMRA TM 63 YONDELIS 63 Pivotal Phase III 63 Fodosine 63 VFEND 63 Pruvel 63 NOXAFIL 63 Fibrillex TM 63 raltegravir 63 Traficet EN 63 Phase #/#a trial 63 lesinurad 63 Femara letrozole 62 BCX# 62 Gleevec imatinib 62 Vandetanib 62 cabazitaxel 62 rNAPc2 62 Reverset 62 TELCYTA 62 anticancer compound 62 adjuvant colon cancer 62 Telavancin 62 abiraterone 62 Corlux 62 thalidomide Thalomid 62 Doxil ® 62 recurrent glioblastoma multiforme 62 Zarnestra 62 HoFH 62 liposomal amphotericin B 62 microbiological eradication 62 lupus nephritis 62 etravirine 62 rilonacept 62 CR# vcMMAE 62 NEVO ™ 62 XmAb# 62 Pirfenidone 62 chlorambucil 62 MyVax R 62 pegylated interferon alpha 62 OvaRex ® MAb 62 ATL/TV# 62 daclizumab 62 Dificid 62 complete cytogenetic response 62 Dasatinib 62 NXL# 62 Pafuramidine 62 gatifloxacin 62 TLK# 62 infliximab Remicade 62 Telaprevir 62 UPLYSO 62 APTIVUS R 62 Prosaptide 62 APPRAISE 62 viral kinetics 62 S/GSK# 62 galiximab 62 PROCHYMAL 62 protease inhibitor PI 62 telbivudine 62 Restanza 62 EOquin TM 62 TYGACIL 62 phase IIa 62 glufosfamide 62 abatacept Orencia 62 baminercept 62 NP2 Enkephalin 62 Tygacil 62 PXD# 62 SCH # 62 Herceptin trastuzumab 62 Arcalyst 62 SUTENT 62 Tasigna nilotinib 62 Thiovir 62 sorafenib tablets 62 comparator arm 62 torezolid 62 HQK 62 Xanafide 62 antithrombotics 62 GRN# 62 Cimzia 62 LymphoStat B belimumab 62 Gleevec imatinib mesylate 62 RhuDex ® 62 tramiprosate Alzhemed TM 62 efalizumab 62 darapladib 62 Jevtana 62 CANCIDAS 62 oritavancin 62 PREZISTA r 62 NVA# 62 vicriviroc 62 Anidulafungin 62 INC# 62 DIFICID 62 Ramoplanin 62 GALNS 62 atrasentan 62 Panzem 62 relapsed MM 62 Irinotecan 62 SAR# [004] 62 microplasmin 62 reslizumab 62 bevacizumab Avastin 62 budesonide foam 62 SNT MC# 62 ACTEMRA 62 docetaxel chemotherapy 62 NATRECOR R 62 paliperidone ER 62 talabostat 62 MERLIN TIMI 62 ImClone Erbitux 62 therapeutic regimens 62 IRX 2 62 oropharyngeal candidiasis 62 Valcyte 62 visilizumab 62 recurrent genital herpes 62 Virulizin ® 62 methylnaltrexone 62 BRIM3 62 phase IIa clinical 62 CaPre TM 62 relapsed ovarian cancer 62 temsirolimus 62 HCV RESPOND 2 62 glatiramer acetate 62 KRAS status 62 faropenem 62 Catena ® 62 Fidaxomicin 62 cobiprostone 62 CBLC# 62 ruxolitinib 62 Enzastaurin 62 Dapagliflozin 62 HCV infections 62 selective modulator 62 abatacept 62 dose cohort 61 Dalbavancin 61 hepatitis C genotype 61 Neuvenge 61 Diovan HCT 61 PEG SN# 61 MYCAMINE 61 Tavocept 61 romidepsin 61 Vernakalant 61 chronic HBV 61 ixabepilone 61 Mycamine 61 personalized immunotherapy 61 INTELENCE 61 Mipomersen 61 Firazyr 61 assessing T DM1 61 rituximab Rituxan 61 ritonavir boosted 61 edoxaban 61 experimental hepatitis C 61 IMGN# 61 Natalizumab 61 Teriflunomide 61 STRIDE PD 61 sunitinib 61 peginterferon 61 Oritavancin 61 antiplatelet agent 61 phase IIb study 61 ZYVOX 61 MyVax 61 Stimuvax R 61 receptor tyrosine kinase inhibitor 61 Cloretazine 61 interferon ribavirin 61 Azedra 61 Nuvion 61 relapsing MS 61 levosimendan 61 DAPT 61 HuLuc# 61 mertansine 61 DXL# 61 BARACLUDE ® 61 BLA filing 61 Plicera 61 nilotinib 61 investigational humanized monoclonal antibody 61 COPD exacerbations 61 CRMD# 61 Proquin XR 61 Folotyn 61 Fluconazole 61 lomitapide 61 TroVax 61 Sorafenib 61 SUTENT ® 61 Kynapid 61 otelixizumab 61 ADAGIO study 61 rivaroxaban 61 midstage studies 61 CIMZIA TM certolizumab pegol 61 ADVANCE PD 61 HERCEPTIN 61 Removab 61 renal toxicity 61 rALLy trial 61 CDP# 61 Amrubicin 61 Advagraf 61 Muraglitazar 61 tolevamer 61 boceprevir 61 chemotherapy induced neutropenia 61 oral vancomycin 61 pegylated interferons 61 cSSSIs 61 Ophena TM 61 indiplon capsules 61 Xelox 61 piperacillin tazobactam 61 lixisenatide 61 KRN# 61 HGS ETR2 61 anagrelide 61 docetaxel Taxotere ® 61 octreotide LAR 61 ROTARIX 61 GLP toxicology studies 61 Factor Xa inhibitor 61 cariprazine 61 EOquin 61 evaluating tivozanib 61 Phase 2b clinical 61 CYT# 61 gadobutrol 61 KIACTA ™ 61 CA4P 61 AZILECT R 61 Radezolid 61 OncoVEX 61 Entecavir 61 teriparatide 61 ibandronate 61 Campath alemtuzumab 61 desvenlafaxine succinate 61 Actemra 61 antiviral efficacy 61 maribavir 61 Cancidas 61 Elocalcitol 61 Ixempra 61 virologic 61 Anthim 61 heavily pretreated 61 Vertex telaprevir 61 trastuzumab Herceptin 61 AZILECT ® 61 Novartis Zometa 61 Apixaban 61 OMAPRO 61 LEP ETU 61 virologic failure 61 neovascular diseases 61 oblimersen 61 oral rivaroxaban 61 DEB# 61 Doribax 61 NSABP C 61 genotypic resistance 61 Sebivo 61 eosinophilic asthma 61 protease inhibitors PIs 61 GOUT 61 PegIntron 61 Rezular 61 vismodegib 61 CMV disease 61 ILLUMINATE 61 Tocosol Paclitaxel 61 CYT# QbG# 61 herpetic keratitis 61 Pemetrexed 61 ofatumumab 61 rFVIIa 61 FASLODEX 61 alvimopan 61 LEXIVA r 61 metastatic HRPC 61 MoxDuo IR 61 motesanib 61 clazosentan 61 Tekturna HCT 61 NATRECOR ® 61 Amigal 61 MabCampath 61 Copegus ribavirin 61 Neulasta ® 61 trastuzumab DM1 T DM1 61 lucinactant 61 corticosteroid dexamethasone 61 Iressa gefitinib 61 tenofovir emtricitabine 61 celgosivir 61 Pazopanib 61 Valortim 61 relapsed refractory multiple myeloma 61 bendamustine 61 DU #b 61 Ocrelizumab 60 Isentress raltegravir 60 LUMINATE 60 AVERROES 60 AVASTIN 60 trabedersen 60 amoxicillin clavulanate 60 dirucotide 60 inhibitor RG# 60 HCD# [002] 60 noninfectious uveitis 60 phase IIb 60 registrational trial 60 sargramostim 60 PRIMO CABG 60 virus HCV protease inhibitor 60 Heplisav 60 antibody MAb 60 heterozygous FH 60 abiraterone acetate 60 TBC# 60 Arranon 60 Zerenex 60 Durezol 60 Erlotinib 60 valvulopathy 60 Altabax 60 PegIFN RBV 60 ZACTIMA 60 dexanabinol 60 Genasense ® 60 Pegintron 60 afatinib 60 CTAP# Capsules 60 pharmacokinetic PK study 60 prostate cancer mCRPC 60 AP# [003] 60 atovaquone 60 Factor VIIa 60 panitumumab Vectibix 60 tolerability profiles 60 randomized Phase IIb 60 ULORIC 60 arzoxifene 60 darunavir 60 Vectibix monotherapy 60 malignant ascites 60 OMNARIS HFA 60 ganciclovir 60 Allovectin 7 60 PTK ZK 60 alkylating agent 60 midstage trials 60 placebo controlled Phase 60 superficial bladder cancer 60 hepatitis C HCV 60 MEND CABG 60 Aclidinium 60 idraparinux 60 pimecrolimus 60 Bezielle 60 Phase Ib II 60 linezolid 60 anti angiogenic agents 60 MGd 60 etanercept Enbrel 60 rizatriptan 60 IL# PE#QQR 60 L BLP# 60 Vibativ 60 MyVax ® 60 Avastin bevacizumab 60 standard chemotherapy regimen 60 Torisel 60 Cloretazine R 60 sustained virologic response 60 anakinra 60 QVA# 60 valacyclovir 60 pexiganan 60 Gleevec Glivec 60 ORENCIA ® 60 angiogenesis inhibitor 60 cethromycin 60 deferiprone 60 Phase 1a clinical 60 non metastatic osteosarcoma 60 trastuzumab Herceptin ® 60 TAXOTERE ® 60 favorable tolerability 60 TELINTRA 60 pralatrexate 60 pegylated liposomal doxorubicin 60 Carfilzomib 60 efficacy tolerability 60 pantoprazole 60 anti leukemic 60 coinfected patients 60 salmeterol fluticasone 60 uridine triacetate 60 CAELYX 60 Bonefos 60 Tindamax R 60 TORISEL 60 #mg BID [001] 60 Triapine R 60 Troxatyl 60 mTOR inhibitor 60 MGN# 60 calcineurin inhibitors 60 metastatic RCC 60 VA# [002] 60 seliciclib 60 tafamidis 60 cIAI 60 Zoraxel 60 Cinryze ™ 60 retapamulin 60 PROMACTA 60 venous thromboembolic events 60 ketolide antibiotic 60 Hyphanox 60 SPRYCEL ® 60 Onrigin 60 ProSavin 60 VIRAMUNE 60 pediatric acute lymphoblastic 60 VELCADE melphalan 60 XELOX 60 cilengitide 60 palifermin 60 sipuleucel T 60 INCB# [003] 60 CCR5 inhibitors 60 subcutaneous formulation 60 Icatibant 60 meropenem 60 Cimzia ® certolizumab pegol 60 HCV SPRINT 60 aripiprazole Abilify 60 CytoFab 60 blinatumomab 60 LibiGel ® 60 Triolex 60 trabectedin 60 Archexin 60 azacitidine 60 ruboxistaurin 60 sapacitabine 60 Pivotal Phase 60 Tocilizumab 60 tipranavir r 60 Atacand 60 thymalfasin 60 Certican 60 XL# SAR# 60 fingolimod 60 telaprevir 60 Pertuzumab 60 Cloretazine ® 60 oral antiviral 60 Cloretazine R VNP#M 60 Phase 2b study 60 Alinia 60 CCX# 60 ribavirin therapy 60 SCCHN 60 AIM HIGH 60 amphotericin B 60 treprostinil 60 lintuzumab 60 CCR5 antagonist 60 postoperative ileus POI 60 Tesetaxel 60 Vidaza azacitidine 60 Azilect ® 60 seroconversion 60 Elacytarabine 60 PEGylated interferon beta 1a 60 LHRH antagonists 60 bicifadine 60 Alvesco R 60 DACH platinum 60 lumiracoxib 60 HspE7 60 metastatic malignant melanoma 60 SUCCEED trial 60 Quinamed 60 SNT-MC#/idebenone 60 SEBIVO 60 dasatinib 60 FluCide 60 PEG interferon 60 trodusquemine 60 Xinlay 60 tolerability profile 60 fulvestrant 60 Tyrima 60 Temsirolimus 60 Hydroxyurea 60 ertapenem 60 oral Xeloda 60 Canvaxin 60 randomized discontinuation trial 60 Invirase 60 FOLPI 60 RSD# oral 60 refractory AML 60 metastatic sarcomas 60 #I TM# 60 mcg dose 60 convenient dosing regimens 60 Vfend 60 Annamycin 60 Epivir 60 Rasilez Tekturna 60 Phase IIb trials 60 ISENTRESS 60 aprepitant 60 TYKERB 60 antithrombotic 60 muraglitazar 60 COMFORT II 60 Tanespimycin 60 mg/m2 dose 60 aflibercept VEGF Trap 60 OncoVex 60 CYPHER Stent 60 REMICADE ® 60 Serdolect ® 60 erlotinib Tarceva 60 EDEMA3 60 eniluracil 60 Pegasys plus Copegus 60 edifoligide 60 noninferiority 60 Luveris 60 AEGR 60 active comparator 60 Phase #b/#a trial 60 relapsed multiple myeloma 60 defibrotide 60 LEUKINE 60 REMINYL ® 59 Pegasys ® 59 ongoing Phase 1b 59 INCB# [002] 59 Gilenia 59 phase IIb III 59 interferon gamma 1b 59 tesmilifene 59 docetaxel Taxotere R 59 intravenous immunoglobulin 59 antimicrobial prophylaxis 59 IRESSA 59 Rivaroxaban 59 MabThera Rituxan 59 uric acid lowering 59 masitinib 59 Zemplar Capsules 59 rolofylline 59 KETEK 59 indolent NHL 59 HBeAg positive patients 59 TRIOLEX 59 Taxotere ® 59 alemtuzumab Campath 59 NV1FGF 59 peg interferon 59 Phase IIa trial 59 LY# [002] 59 Vitaxin 59 treatment naive genotype 59 Famvir 59 Seliciclib 59 metastatic CRC 59 noscapine 59 Alocrest 59 TREDAPTIVE 59 myelodysplastic myeloproliferative diseases 59 Abiraterone 59 Tarceva erlotinib 59 TACI Ig 59 Prostate AdenoCarcinoma Treatment 59 ARCALYST 59 Erbitux cetuximab 59 BrachySil TM 59 Panzem R 59 Adalimumab 59 RoACTEMRA 59 Phase IIb clinical trials 59 ACUITY trial 59 sustained virological response 59 tofacitinib 59 relapsing remitting MS RRMS 59 IND submission 59 mg kg dose 59 Aloxi injection 59 MIRCERA 59 neuraminidase inhibitor 59 DDP# 59 ustekinumab 59 MAA submission 59 Genentech Rituxan 59 RGB # 59 Pegasys peginterferon alfa 2a 59 AZT zidovudine Retrovir 59 LUX Lung 59 MAXY alpha 59 Civacir 59 biologic therapy 59 BARACLUDE R 59 QNEXA 59 fostamatinib 59 Theratope 59 eritoran 59 Hycamtin 59 TREANDA 59 tasocitinib 59 ON #.Na 59 fluvastatin 59 TPI ASM8 59 integrase inhibitor 59 Pixuvri 59 Zalbin 59 Omigard 59 Emselex 59 Denufosol 59 antibiotic ceftobiprole 59 REP# 59 placebo controlled clinical 59 Cytoxan 59 LE DT 59 Maraviroc 59 #D#C# 59 tipifarnib 59 Serdaxin 59 trastuzumab DM1 59 vorinostat 59 YERVOY 59 dose cohorts 59 Zavesca R 59 sJIA 59 TYZEKA 59 GPIIb IIIa 59 cystinosis patients 59 Phase 2b trial 59 Degarelix 59 ARIXTRA 59 pharmacokinetic interactions 59 Dr. McHutchison 59 CEQ# 59 AEG# 59 receptor inhibitor 59 TNF antagonist 59 CorVue ™ 59 antiviral therapy 59 picoplatin 59 anthracyclines taxanes 59 EDEMA4 59 GFT# 59 Itopride 59 FTY# fingolimod 59 PROVENGE sipuleucel T 59 T DM1 59 Dacogen decitabine 59 rALLy 59 PEG PAL 59 aldosterone antagonists 59 Omacetaxine 59 Fx #A 59 Telcyta 59 natalizumab 59 adalimumab 59 relapsing remitting multiple sclerosis 59 vildagliptin 59 macrolide antibiotics 59 herpes zoster shingles 59 RAD# everolimus 59 febrile neutropenia 59 Kivexa 59 favorable pharmacokinetic profile 59 Tekamlo 59 CALGB # [002] 59 Vectibix panitumumab 59 trospium 59 miconazole Lauriad ® 59 randomized multicenter Phase III 59 Privigen 59 VAPRISOL 59 dose escalation clinical 59 rALLy clinical trial 59 ONGLYZA ™ 59 Starlix 59 Valortim R 59 tecarfarin 59 antibiotic prophylaxis 59 RSR# 59 secondary efficacy endpoints 59 L MTP PE 59 Gattex 59 Stelara 59 rEV# 59 vascular disrupting agent 59 Fibrillex 59 IV bisphosphonates 59 imatinib resistance 59 clopidogrel Plavix 59 TKI therapy 59 alfa 2a 59 Glufosfamide 59 anticancer therapy 59 Onconase 59 EFAPROXYN 59 Urocidin 59 FOLOTYN ® 59 Vicinium TM 59 Mozobil 59 Abacavir 59 Cimzia ® 59 maximally tolerated dose 59 antitumor effect 59 erlotinib Tarceva ® 59 imatinib Gleevec ® 59 paclitaxel Taxol 59 Merck Isentress 59 non peptidic protease 59 Omapro 59 LMWH 59 Diamyd ® 59 dabigatran etexilate 59 allogeneic HSCT 59 achieved sustained virological 59 AMN# [001] 59 CoFactor 59 Hepatocellular Carcinoma HCC 59 Mylotarg 59 PEARL SC 59 Relovair 59 ribavirin RBV 59 Octreolin 59 omega interferon 59 dosage regimens 59 investigational compound 59 Benlysta belimumab 59 VIR# 59 Virologic 59 lurasidone 59 Gilead Viread 59 Certolizumab pegol 59 GSK# [002] 59 RE SURGE 59 Roche Xeloda 59 Cubicin 59 pivotal bioequivalence 59 Vicriviroc 59 apricitabine 59 HER2 positive metastatic breast 59 randomized Phase III 59 almorexant 59 fluconazole 59 ThGRF 59 immunosuppressant drug 59 oral deforolimus 59 NEUVENGE 59 Panitumumab 59 Phase 1b trial 59 FluINsure 59 chemopreventive agent 59 Hexvix 59 EVIZON 59 platinum refractory 59 acyclovir Lauriad R 59 HPV-#/# 59 TG# [003] 59 BNC# 59 deforolimus 59 nucleoside analog 59 Votrient 59 recurrent glioblastoma 59 Raptiva ®